menu
    • menu

    Company profile for Mosaic Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Ca...
    Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety of oncology indications and disease biology pathways.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mosaic Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    BioData Innovation Centre Wellcome Genome Campus Hinxton, Cambridgeshire CB1...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://mosaic-tx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mosaic-tx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mosaic Therapeutics Appoints Shuttleworth Chief Scientific
    Mosaic Therapeutics Appoints Shuttleworth Chief Scientific

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251117068628/en/Mosaic-Therapeutics-appoints-Dr-Stephen-Shuttleworth-as-Chief-Scientific-Officer

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    Mosaic Therapeutics Appoints Thomas Fuchs As CEO
    Mosaic Therapeutics Appoints Thomas Fuchs As CEO

    20 Oct 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251020841174/en/Mosaic-Therapeutics-Appoints-Thomas-Fuchs-as-CEO

    BUSINESS WIRE
    20 Oct 2025
    Share Share
    Mosaic licenses 2 clinical stage tumor drugs from Otsuka's Astex
    Mosaic licenses 2 clinical stage tumor drugs from Otsuka's Astex

    24 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/mosaic-adds-cancer-combo-pattern-licensing-2-clinical-stage-drugs-astex

    FIERCE BIOTECH
    24 Apr 2025
    Share Share
    Mosaic Closes $28m Series A Funding and Appoints Brian Gladsden as CEO
    Mosaic Closes $28m Series A Funding and Appoints Brian Gladsden as CEO

    04 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230404005673/en

    BUSINESSWIRE
    04 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search